These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8183761)

  • 1. Prolonged remission of hypercalcaemia due to parathyroid carcinoma with pamidronate.
    Newrick PG; Braatvedt GD; Webb AJ; Sheffield E; Corrall RJ
    Postgrad Med J; 1994 Mar; 70(821):231-2. PubMed ID: 8183761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.
    Fraser WD; Logue FC; Gallacher SJ; O'Reilly DS; Beastall GH; Ralston SH; Boyle IT
    Bone Miner; 1991 Feb; 12(2):113-21. PubMed ID: 1849762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disodium clodronate effective in management of severe hypercalcaemia caused by parathyroid carcinoma.
    Jüngst D
    Lancet; 1984 Nov; 2(8410):1043. PubMed ID: 6149425
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimally symptomatic severe hypercalcaemia in a patient with parathyroid carcinoma.
    Sheikh A; Islam N
    J Pak Med Assoc; 2006 Jan; 56(1):40-1. PubMed ID: 16454135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous pamidronate for hypercalcemia of primary hyperparathyroidism.
    Tal A; Graves L
    South Med J; 1996 Jun; 89(6):637-40. PubMed ID: 8638211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-related protein(50-69) and response to pamidronate therapy for tumour-induced hypercalcaemia.
    Dodwell DJ; Abbas SK; Morton AR; Howell A
    Eur J Cancer; 1991; 27(12):1629-33. PubMed ID: 1782072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma.
    Pak CY; Wills MR; Smith GW; Bartter FC
    J Clin Endocrinol Metab; 1968 Nov; 28(11):1657-60. PubMed ID: 5697042
    [No Abstract]   [Full Text] [Related]  

  • 8. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma.
    Rasmuson T; Kristoffersson A; Boquist L
    Eur J Endocrinol; 2000 Dec; 143(6):749-54. PubMed ID: 11124857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia.
    Gurney H; Grill V; Martin TJ
    Lancet; 1993 Jun; 341(8861):1611-3. PubMed ID: 8099988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous occurrence of parathyroid carcinoma and adenoma in an elderly woman.
    Shapiro DM; Recant W; Hemmati M; Mazzone T; Evans RH
    Surgery; 1989 Nov; 106(5):929-33. PubMed ID: 2814826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating PTH and PTHrP levels before and after treatment of tumor induced hypercalcemia with Pamidronate Disodium (APD).
    Grill V; Murray RM; Ho PW; Santamaria JD; Pitt P; Potts C; Jerums G; Martin TJ
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1468-70. PubMed ID: 1592895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term control of hypercalcaemia in an infant with williams-Beuren syndrome after a single infusion of biphosphonate (Pamidronate).
    Oliveri B; Mastaglia SR; Mautalen C; Gravano JC; Pardo Argerich L
    Acta Paediatr; 2004 Jul; 93(7):1002-3. PubMed ID: 15303821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Just hypercalcaemia or acute ST elevation myocardial infarction? A review of hypercalcaemia-related electrocardiographic changes.
    Patnaik S; Lai YK
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26490999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pamidronate treatment in patients with tumor-associated hypercalcemia: pharmacological effects and pharmacokinetics.
    Oiso Y; Tomita A; Hasegawa H; Ariyoshi Y; Niinomi M; Yamamoto M; Takano T; Sakiyama N
    Endocr J; 1994 Dec; 41(6):655-61. PubMed ID: 7704089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refractory hypercalcaemia secondary to parathyroid carcinoma: response to high-dose denosumab.
    Karuppiah D; Thanabalasingham G; Shine B; Wang LM; Sadler GP; Karavitaki N; Grossman AB
    Eur J Endocrinol; 2014 Jul; 171(1):K1-5. PubMed ID: 24743399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe prolonged hypocalcaemia following pamidronate for malignant hypercalcaemia.
    Sims EC; Rogers PB; Besser GM; Plowman PN
    Clin Oncol (R Coll Radiol); 1998; 10(6):407-9. PubMed ID: 9890546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of hypercalcemia with ibandronate in case of acute renal failure].
    Bergner R; Henrich DM; Hoffmann M; Bruckner D; Uppenkamp M
    Internist (Berl); 2006 Mar; 47(3):293-6. PubMed ID: 16470360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medullary carcinoma of the thyroid with parathyroid adenoma and hypercalcaemia.
    MacGillivray JB; Anderson CJ
    J Clin Pathol; 1971 Dec; 24(9):851-5. PubMed ID: 5139990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial medullary carcinoma and parathyroid adenoma without pheochromocytoma. Report of two cases.
    Markey WS; Ryan WG; Economou SG; Sizemore GW; Arnaud CD
    Ann Intern Med; 1973 Jun; 78(6):898-901. PubMed ID: 4713572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.